Investigating Lysosomal Storage Diseases in Minority Groups

Recruitment Status
STATUS NOT REPORTED
(See Contacts and Locations)Verified March 2017 by O & O Alpan LLC
Sponsor
O & O Alpan LLC
Information Provided by (Responsible Party)
O & O Alpan LLC
Clinicaltrials.gov Identifier
NCT02120235
Other Study ID Numbers:
14-CFCT-11
First Submitted
April 16, 2014
First Posted
April 21, 2014
Last Update Posted
April 3, 2017
Last Verified
March 2017

ClinicalTrials.gov processed this data on April 2017. Link to the current ClinicalTrials.gov record .

History of Changes

Study Details

Study Description

Condition or DiseaseIntervention/Treatment
Lysosomal Storage DisordersGaucher DiseaseFabry DiseasePompe DiseaseNiemann-Pick Disease

Study Design

Study TypeObservational
Actual Enrollment20000 participants
Study Start DateJanuary 31, 2014
Actual Primary Completion DateJanuary 31, 2018
Actual Study Completion DateNovember 30, 2018

Outcome Measures

Primary Outcome Measures
  1. Number of patients identified with lysosomal storage disorders

Eligibility Criteria

Ages Eligible for Study(Child, Adult, Older Adult)
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Inclusion Criteria
Subject is greater than or equal to 1 day of age and less than or equal to 100 years of age
Subject is managed by a physician in the Washington, D.C metro area
Subject is getting blood work as part of standard clinical care and there is at least 60 uL blood remained in a tube after all clinical tests were run
Exclusion Criteria
Absolute contraindication for blood drawing
Subject cannot be traced back by the referring physician upon a positive screening result

Contacts and Locations

Sponsors and CollaboratorsO & O Alpan LLC
Locations
O&O Alpan, LLC | Fairfax Virginia, United States, 22030